257 related articles for article (PubMed ID: 36181495)
1. Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men.
Tran NK; Martinez O; Scheim AI; Goldstein ND; Welles SL
AIDS Educ Prev; 2022 Oct; 34(5):365-378. PubMed ID: 36181495
[TBL] [Abstract][Full Text] [Related]
2. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
Parsons JT; Rendina HJ; Whitfield TH; Grov C
AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
[TBL] [Abstract][Full Text] [Related]
3. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
[TBL] [Abstract][Full Text] [Related]
4. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
[TBL] [Abstract][Full Text] [Related]
5. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
[TBL] [Abstract][Full Text] [Related]
6. Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada.
Grace D; Gaspar M; Wells A; Sinno J; Daroya E; Montess M; Hull M; Lachowsky NJ; Tan DHS
AIDS Patient Care STDS; 2023 Jun; 37(6):306-315. PubMed ID: 37195728
[TBL] [Abstract][Full Text] [Related]
7. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
Reyniers T; Fiorentino M; Babo SAY; Ouedraogo M; Kanta I; Agbegnigan LE; Rojas D; Anoma C; Dah TTE; Mensah E; Keita BD; Spire B; Vuylsteke B; Laurent C
AIDS Patient Care STDS; 2023 Oct; 37(10):480-488. PubMed ID: 37862074
[TBL] [Abstract][Full Text] [Related]
8. Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.
Dean LT; Predmore Z; Skinner A; Napoleon S; Chan PA; Raifman J
AIDS Behav; 2023 Aug; 27(8):2606-2616. PubMed ID: 36670210
[TBL] [Abstract][Full Text] [Related]
9. Preferences for long-acting pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey.
Hsu JH; Ku SW; Chen TW; Li CW; Huang P; Wu HJ; Bourne A; Strong C
J Int AIDS Soc; 2023 Sep; 26(9):e26163. PubMed ID: 37675767
[TBL] [Abstract][Full Text] [Related]
10. Willingness to Use Long-Acting Injectable PrEP Among PrEP Naïve Black and Hispanic Sexual Gender Minority Persons.
Okafor CN; Eaton L; Watson R
AIDS Behav; 2024 Jun; 28(6):2166-2174. PubMed ID: 38526639
[TBL] [Abstract][Full Text] [Related]
11. Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia.
Chan C; Vaccher S; Fraser D; Grulich AE; Holt M; Zablotska-Manos I; Prestage GP; Bavinton BR
AIDS Behav; 2022 Jan; 26(1):88-95. PubMed ID: 34142274
[TBL] [Abstract][Full Text] [Related]
12. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
[TBL] [Abstract][Full Text] [Related]
13. Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil.
Pedrana L; Magno L; Zucchi EM; da Silva LAV; Ferraz D; Grangeiro A; Castellanos M; Brasil SA; Dourado I
BMC Public Health; 2022 Sep; 22(1):1728. PubMed ID: 36096758
[TBL] [Abstract][Full Text] [Related]
14. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
[TBL] [Abstract][Full Text] [Related]
15. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
16. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
[TBL] [Abstract][Full Text] [Related]
17. To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.
Meyers K; Wu Y; Brill A; Sandfort T; Golub SA
PLoS One; 2018; 13(7):e0200296. PubMed ID: 30024903
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
[TBL] [Abstract][Full Text] [Related]
19. EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP).
Kaul CM; Moore BE; Kaplan-Lewis E; Casey E; Pitts RA; Pagan Pirallo P; Lim S; Kapadia F; Cohen GM; Khan M; Mgbako O
PLoS One; 2023; 18(9):e0291657. PubMed ID: 37725628
[TBL] [Abstract][Full Text] [Related]
20. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
